This topic contains a solution. Click here to go to the answer

Author Question: Which of the following would the HIM consultant be LEAST likely to research in preparing to conduct ... (Read 106 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
Which of the following would the HIM consultant be LEAST likely to research in preparing to conduct a documentation audit?
 A) federal and state regulations for the type of facility being audited
  B) accreditation guidelines
  C) HIPAA EDI standards
  D) best practices

Question 2

Individuals who are the primary recipients of the managed care insurance benefit within a managed care organization are referred to as _______________.
 A) patients
  B) dependents
  C) subscribers
  D) beneficiaries



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

af

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

C

Answer to Question 2

C




captainjonesify

  • Member
  • Posts: 543
Reply 2 on: Jul 12, 2018
Wow, this really help


miss.ashley

  • Member
  • Posts: 371
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library